help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PIZZICHINI, E.
Right arrow Articles by HARGREAVE, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PIZZICHINI, E.
Right arrow Articles by HARGREAVE, F. E.

Am. J. Respir. Crit. Care Med., Volume 158, Number 5, November 1998, 1511-1517

Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis

EMILIO PIZZICHINI, MARCIA M. M. PIZZICHINI, PETER GIBSON, K. PARAMESWARAN, GERALD J. GLEICH, LES BERMAN, JERRY DOLOVICH, and FREDERICK E. HARGREAVE

Departments of Medicine and Paediatrics, St. Joseph's Hospital and McMaster University, Hamilton, Ontario, Canada; Department of Respiratory Medicine, John Hunter Hospital, Newcastle, Australia; and Departments of Immunology and Medicine, Mayo Clinic and Foundation, Rochester, Minnesota

A reliable predictor of benefit from corticosteroid treatment in patients with chronic airflow limitation is needed. In a single-blind, sequential crossover trial of placebo and prednisone (30 mg/day) treatment, with each given for 2 wk, we investigated whether an increased proportion of sputum eosinophils (>=  3%) predicts a beneficial effect of prednisone in smokers with severe obstructive bronchitis. Patients were seen before and after each treatment. Clinical measurements were made blind to the laboratory findings and vice-versa. Eighteen of 20 patients completed the study. Eight had sputum eosinophilia and similar clinical and physiologic characteristics to those of 10 patients without a finding of sputum eosinophilia. Only in patients with sputum eosinophilia did prednisone, as compared with placebo, produce a statistically significant and clinically important mean effect on effort dyspnea of 0.8 (95% confidence interval [CI]: 0.3 to 1.2), p = 0.008, and in quality of life of 1.96 (95% CI: 0.5 to 3.3), p = 0.01, associated with a small improvement in FEV1 of 0.11 L (95% CI: - 0.04 to 0.23 L), p = 0.05. In these patients, prednisone also produced a significant decline in the median sputum eosinophil percentage, from 9.7% to 0.5% (p = 0.002), eosinophil cationic protein (ECP), from 6,000 µg/L to 1,140 µg/L (p < 0.001), and fibrinogen, from 25.3 mg/L to 5.4 mg/L (p < 0.001). These findings indicate that in smokers with severe airflow limitation, sputum eosinophilia predicts a beneficial effect of prednisone treatment. Improvement in FEV1, after prednisone treatment in this population, is small, and may not be appreciated in clinical practice.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
J. F. Dummer, M. J. Epton, J. O. Cowan, J. M. Cook, R. Condliffe, C. E. Landhuis, A. D. Smith, and D. R. Taylor
Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease Using Exhaled Nitric Oxide
Am. J. Respir. Crit. Care Med., November 1, 2009; 180(9): 846 - 852.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 Ther Adv Respir DisHome page
K. M. Kunisaki, K. L. Rice, E. N. Janoff, T. S. Rector, and D. E. Niewoehner
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 55 - 64.
[Abstract] [PDF]

Home page
 ChestHome page
N. Hizawa, H. Makita, Y. Nasuhara, T. Betsuyaku, Y. Itoh, K. Nagai, M. Hasegawa, and M. Nishimura
{beta}2-Adrenergic Receptor Genetic Polymorphisms and Short-term Bronchodilator Responses in Patients With COPD
Chest, November 1, 2007; 132(5): 1485 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste
Exhaled nitric oxide measurements: clinical application and interpretation
Thorax, September 1, 2006; 61(9): 817 - 827.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. E. Hargreave and K. Parameswaran
Asthma, COPD and bronchitis are just components of airway disease.
Eur. Respir. J., August 1, 2006; 28(2): 264 - 267.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Leigh, M. M. M. Pizzichini, M. M. Morris, F. Maltais, F. E. Hargreave, and E. Pizzichini
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Eur. Respir. J., May 1, 2006; 27(5): 964 - 971.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R O'Donnell, D Breen, S Wilson, and R Djukanovic
Inflammatory cells in the airways in COPD
Thorax, May 1, 2006; 61(5): 448 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. Jayaram, M. M. Pizzichini, R. J. Cook, L-P. Boulet, C. Lemiere, E. Pizzichini, A. Cartier, P. Hussack, C. H. Goldsmith, M. Laviolette, et al.
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.
Eur. Respir. J., March 1, 2006; 27(3): 483 - 494.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. E. Brightling
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 116S - 121S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Hargreave and K. Parameswaran
Efficacy of fluticasone on cough
Eur. Respir. J., July 1, 2005; 26(1): 181 - 181.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
B. P. Ponsioen, P. N. R. Dekhuijzen, A. M. Bohnen, and N. A. Vermue
From the authors
Eur. Respir. J., July 1, 2005; 26(1): 181 - 182.
[Full Text] [PDF]

Home page
 ThoraxHome page
C E Brightling, S McKenna, B Hargadon, S Birring, R Green, R Siva, M Berry, D Parker, W Monteiro, I D Pavord, et al.
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease
Thorax, March 1, 2005; 60(3): 193 - 198.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
J. F. Donohue and J. A. Ohar
Effects of Corticosteroids on Lung Function in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 152 - 160.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D.-W. Perng, H.-Y. Huang, H.-M. Chen, Y.-C. Lee, and R.-P. Perng
Characteristics of Airway Inflammation and Bronchodilator Reversibility in COPD: A Potential Guide to Treatment
Chest, August 1, 2004; 126(2): 375 - 381.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Cazzola and R. Dahl
Inhaled Combination Therapy With Long-Acting {beta}2-Agonists and Corticosteroids in Stable COPD
Chest, July 1, 2004; 126(1): 220 - 237.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.O. Crapo, R.L. Jensen, and F.E. Hargreave
Airway inflammation in COPD: physiological outcome measures and induced sputum
Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Godon, L-P. Boulet, J-L. Malo, A. Cartier, and C. Lemiere
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Eur. Respir. J., December 1, 2002; 20(6): 1364 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Leader of the Working Group: E. Pizzichini, Members of the Working Group:, M.M.M. Pizzichini, R. Leigh, R. Djukanovic, and P.J. Sterk
Safety of sputum induction
Eur. Respir. J., July 1, 2002; 20(37_suppl): 9S - 18s.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
Leader of the Working Group:, I.D. Pavord, Members of the Working Group:, P.J. Sterk, F.E. Hargreave, J.C. Kips, M.D. Inman, R. Louis, M.M.M. Pizzichini, E.H. Bel, et al.
Clinical applications of assessment of airway inflammation using induced sputum
Eur. Respir. J., July 1, 2002; 20(37_suppl): 40S - 43s.
[Full Text] [PDF]

Home page
 ChestHome page
W. I. de Boer
Cytokines and Therapy in COPD* : A Promising Combination?
Chest, May 1, 2002; 121 (2009): 209S - 218S.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P G Gibson, M Fujimura, and A Niimi
Eosinophilic bronchitis: clinical manifestations and implications for treatment
Thorax, February 1, 2002; 57(2): 178 - 182.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A E Tattersfield and T W Harrison
Inhaled steroids for COPD?
Thorax, September 1, 2001; 56(90002): ii2 - 6.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. O'BRIEN, P. RUSSO-MAGNO, A. KARKI, S. HIRANNIRAMOL, M. HARDIN, M. KASZUBA, C. SHERMAN, and S. ROUNDS
Effects of Withdrawal of Inhaled Steroids in Men with Severe Irreversible Airflow Obstruction
Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 365 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
U. Costabel
Bronchial Eosinophilia in Exacerbation of Bronchitis . An Allergic Profile of Inflammation?
Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 3 - 4.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. ZHU, Y. S. QIU, S. MAJUMDAR, E. GAMBLE, D. MATIN, G. TURATO, L. M. FABBRI, N. BARNES, M. SAETTA, and P. K. JEFFERY
Exacerbations of Bronchitis . Bronchial Eosinophilia and Gene Expression for Interleukin-4, Interleukin-5, and Eosinophil Chemoattractants
Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 109 - 116.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P MAESTRELLI, L RICHELDI, M MORETTI, and L M FABBRI
Analysis of sputum in COPD
Thorax, June 1, 2001; 56(6): 420 - 422.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. SAETTA, G. TURATO, P. MAESTRELLI, C. E. MAPP, and L. M. FABBRI
Cellular and Structural Bases of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1304 - 1309.
[Full Text]

Home page
 ChestHome page
A. Sayiner, Z. A. Aytemur, M. Cirit, and I. Unsal
Systemic Glucocorticoids in Severe Exacerbations of COPD
Chest, March 1, 2001; 119(3): 726 - 730.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. PAPI, M. ROMAGNOLI, S. BARALDO, F. BRACCIONI, I. GUZZINATI, M. SAETTA, A. CIACCIA, and L. M. FABBRI
Partial Reversibility of Airflow Limitation and Increased Exhaled NO and Sputum Eosinophilia in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1773 - 1777.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A. Hill, S. Gompertz, and R. Stockley
Factors influencing airway inflammation in chronic obstructive pulmonary disease
Thorax, November 1, 2000; 55(11): 970 - 977.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. PAREDI, S. A. KHARITONOV, D. LEAK, S. WARD, D. CRAMER, and P. J. BARNES
Exhaled Ethane, a Marker of Lipid Peroxidation, Is Elevated in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 369 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. McGarvey, L. Heaney, J. MacMahon, M. Ennis, M. Fujimura, C. E. Brightling, and J. D. Pavord
EOSINOPHILIC BRONCHITIS IS AN IMPORTANT CAUSE OF CHRONIC COUGH
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1764 - 1765.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES
REBUTTAL FROM DR. BARNES
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 344a - 344.
[Full Text]

Home page
 ThoraxHome page
A. Bhowmik, T. A R Seemungal, R. J Sapsford, and J. A Wedzicha
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Thorax, February 1, 2000; 55(2): 114 - 120.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. G. COSIO and A. GUERASSIMOV
Chronic Obstructive Pulmonary Disease . Inflammation of Small Airways and Lung Parenchyma
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S21 - 25.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. E. HARGREAVE and R. LEIGH
Induced Sputum, Eosinophilic Bronchitis, and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S53 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. S. POSTMA and H. A. M. KERSTJENS
Are Inhaled Glucocorticosteroids Effective in Chronic Obstructive Pulmonary Disease?
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S66 - 71.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P J STERK, H W F M DE GOUW, F L M RICCIARDOLO, and K F RABE
Exhaled nitric oxide in COPD: glancing through a smoke screen
Thorax, July 1, 1999; 54(7): 565 - 567.
[Full Text]

Home page
 NEJMHome page
H. A. Boushey
Glucocorticoid Therapy for Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 24, 1999; 340(25): 1990 - 1991.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  CCM abstracts